Results
|
101.
|
|
|
102.
|
|
|
103.
|
|
|
104.
|
|
|
105.
|
|
|
106.
|
|
|
107.
|
|
|
108.
|
|
|
109.
|
|
|
110.
|
|
|
111.
|
|
|
112.
|
|
|
113.
|
|
|
114.
|
|
|
115.
|
|
|
116.
|
|
|
117.
|
|
|
118.
|
|
|
119.
|
Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report. [electronic resource] by
- Shah, V P
- Midha, K K
- Dighe, S
- McGilveray, I J
- Skelly, J P
- Yacobi, A
- Layloff, T
- Viswanathan, C T
- Cook, C E
- McDowall, R D
Producer: 19921008
In:
European journal of drug metabolism and pharmacokinetics vol. 16
Availability: No items available.
|
|
120.
|
The novel progesterone receptor antagonists RTI 3021-012 and RTI 3021-022 exhibit complex glucocorticoid receptor antagonist activities: implications for the development of dissociated antiprogestins. [electronic resource] by
- Wagner, B L
- Pollio, G
- Giangrande, P
- Webster, J C
- Breslin, M
- Mais, D E
- Cook, C E
- Vedeckis, W V
- Cidlowski, J A
- McDonnell, D P
Producer: 19990323
In:
Endocrinology vol. 140
Availability: No items available.
|